Skip to main content
Explore AMA Products
  • FREIDA™
  • CME from AMA Ed Hub™
  • Career Advancement
  • AMA Physician Profiles
  • Well-Being
  • Store
  • CPT®
  • Audio
  • Newsletters
  • Video
  • Public Health
      1. Public Health
      2. Infectious Diseases
      3. Chronic Diseases
      4. Injury & Violence
      5. Environmental Health
      6. Optimal Health
      7. Prevention & Wellness
      8. Population Health
      9. Behavioral Health
      Older adult coughing

      What doctors want patients to know about pneumonia

      Pneumonia is an infection of the lungs with severity that should not be underestimated. Abdul M. Khan, MD, a pulmonologist at Ochsner Health, shares more.

      Is it arthritis? Watch for these early warning signs

      Are your aches and pains just part of getting older, or could they be signs of arthritis?

  • Practice Management
      1. Practice Management
      2. AMA Credentialing Solutions
      3. AMA STEPS Forward®
      4. AMA Guides®
      5. AMA Store
      6. Organization Well-Being
      7. CPT®
      8. Prior Authorization
      9. Reducing Administrative Burden
      10. Scope of Practice
      11. Sustainability
      12. Physician Health
      13. Claims Processing
      14. Private Practices
      15. Payment & Delivery Models
      16. Medicare & Medicaid
      17. Digital
      18. HIPAA
      19. Career Development
      Physician holds a question mark

      Fellowship or practice? How resident physicians can choose wisely

      Not sure whether subspecializing is right for you? Residents who chose both paths share how they weighed fit, lifestyle, debt and long-term goals.

      Physician and patient review information on a tablet

      Building a better system of care for physicians and patients

      Vicki LoPachin, MD, talks about her new role as executive vice president and chief medical officer and her plans to support Atlantic Health physicians.

  • Education
      1. Education
      2. AMA PRA Credit System
      3. Improve GME
      4. GME Funding
      5. Medical School Diversity
      6. ChangeMedEd Initiative
      7. International Med Ed

      Medical education webinars and podcasts

      Register for upcoming ChangeMedEd webinars, watch webinars on-demand and listen to episodes from the Catalyzing Change in MedEd podcast series.

      Teaching health systems science

      Understand the evolving field of health systems science and acquire the necessary tools and skills to successfully share this approach with medical students.

  • Students
      1. Students
      2. Prep for Med School
      3. Succeed in Med School
      4. Prep for Residency
      5. Med Student Advocacy
      6. Student Members
      Smiling physician

      How medical student advocacy shapes your path to residency

      Why our program? Why this specialty? When residency applications roll around, advocacy and public health policy work can help make the answers clear.

      Speech balloon filled with smaller speech balloons

      Medical students: How to write a public comment, shape health policy

      A federal process to gain feedback on proposed regulations offers medical students a voice in health policy. Learn how to get started.

  • Residents
      1. Residents
      2. Residency Life
      3. Research in Residency
      4. Medical Fellowships
      5. Resident Wellness
      6. Resident Advocacy
      7. Residency Finance
      8. USMLE® Step 3
      9. Transition to Attending
      Paintbrushes and watercolor palette

      The one thing I do for myself in physician residency training

      Explore the real self-care strategies that resident physicians use to stay grounded, recharge and thrive in training.

      Finger pushes up one block in a row of blocks

      Considering fellowship? Check in on the latest applicant trends

      The competitiveness picture looks different for fellowship. Dive into the NRMP’s 2026 appointment-year fellowship Match data for subspecialty information.

  • Advocacy
      1. Advocacy
      2. Public Health Advocacy
      3. Access to Care
      4. Administrative Burdens
      5. Payment Reform
      6. Advocacy Update
      7. Federal Advocacy
      8. State Advocacy
      9. Judicial Advocacy
      Person filling out a form on a clipboard

      Competition in healthcare research

      Learn about the current state of competition in health insurance markets across the U.S. and review in-depth analysis on market concentration.

      Ensuring health insurance competition

      Discover the AMA's position on health insurance mergers and why the AMA believes fewer insurance carriers undermine physician practices and harm patient care.

  • Membership
      1. Membership
      2. Physician Membership
      3. Resident & Fellow Membership
      4. Student Membership
      5. Benefits & Discounts
      6. Become a Member
      7. Events
      8. Online CME

      CPT Editorial Panel widespread use criteria town hall

      Register for the AMA town hall to learn about how the widespread use criteria is used to evaluate requests for Category I CPT codes.

      Advocacy Insights webinar logo

      Outlook on how the new Congress may address Medicare and Medicaid

      In this Advocacy Insights webinar, learn about AMA’s latest advocacy on Medicare payment and Medicaid. Register now.

  • Organization
  • Board of Trustees
  • House of Delegates
      1. House of Delegates
      2. HOD Organization
      3. AMA Policies
      4. Annual Meeting
      5. Interim Meeting
      6. AMA Elections

      Council & committee applications

      Details provided on the application process and deadlines for physicians, residents and medical students interested in joining AMA council and committees.

      Future meetings of the AMA House of Delegates

      Review the dates for future Annual and Interim Meetings of the AMA House of Delegates and AMA policy on meeting locations.

  • Councils
      1. Councils
      2. Constitution & Bylaws
      3. Ethical & Judicial Affairs
      4. Legislation
      5. Long Range Planning & Development
      6. Medical Education
      7. Medical Service
      8. Science & Public Health

      Consumer-driven healthcare: Council on Medical Service reports

      Download PDFs of key council reports that advance policies that emphasize patient choice and control of their healthcare by addressing high-value care, retail/store-based clinics, addiction treatment centers, genetic/genomic precision medicine, telemedicine, insurance coverage options, reference pricing, prescription drugs, and hospital care coordination.

      Drug coverage & spending: Council on Medical Service reports

      Download PDFs of council reports that have proposed strategies to address high and escalating prescription drug prices and costs, including promoting transparency and pharmaceutical market competition, combating anti-competitive practices, and outlining criteria for value-based pricing and prescription drug importation.

  • Member Groups (Sections)
      1. Member Groups (Sections)
      2. Section Meetings
      3. Academic Physicians
      4. AI/AN Affairs
      5. Integrated Physician Practices
      6. International Medical Graduates
      7. LGBTQ+ Section
      8. Medical Students
      9. Organized Medical Staff
      10. Private Practice Physicians
      11. Residents & Fellows
      12. Senior Physicians
      13. Underrepresented in Medicine
      14. Women Physicians
      15. Young Physicians

      Underrepresented in Medicine Advocacy Section (UMAS) leadership opportunities

      The AMA is your ally in providing you with opportunities in the UMAS to develop your leadership skills and advocate for patients and the profession.

      About the Private Practice Physicians Section (PPPS)

      The Private Practice Physicians Section (PPPS) seeks to preserve the freedom, independence and integrity of private practice.

  • About
      1. About
      2. AMA Center for Digital Health and AI
      3. AMA Center for Optimal Health Outcomes
      4. Board of Trustees
      5. Leadership
      6. Foundation
      7. Office of International Relations
      8. CPT® Editorial Panel
      9. RVS Update Committee (RUC)
      10. United States Adopted Names
      11. Publications & Newsletters
      12. Research
      13. AMA History
      14. Awards
      15. AMA Career Opportunities
      16. Physician Professional Data™
      17. Authors of News & Leadership Viewpoints
      18. Ethics

      CPT® workgroups and committees

      Find out more about the CPT Digital Medicine Coding Committee, Maternity Care Services Workgroup, Value-Based Care Workgroup and Neurostimulator Workgroup. 

      Ensuring physician database privacy

      See who can license the AMA Physician Professional Data™ database, download the PDF for a list of database licensees (DBLs), and how to opt out of the data record.

  • Explore Products
  • FREIDA™
  • CME from AMA Ed Hub™
  • Career Advancement
  • AMA Physician Profiles
  • Well-Being
  • Store
  • CPT®
  • Audio
  • Newsletters
  • Video
American Medical Association
Join Renew
Join or Renew

Popular Searches

  • vaccine recommendations
  • membership
  • cme
  • cpt
  • career advancement collective
Member Benefits
Sign In To Enjoy Your AMA Benefits
  • Sign In
  • Become a Member
  • Create Free Account
My Subscriptions My Topics My Bookmarks
Advocacy Advocacy Update

Aug. 21, 2026: National Advocacy Update

Aug 21, 2026 | 6 Min Read
Member Benefits
Save
Print
Share

Share via Email Share to Facebook Share to Twitter Share to Bluesky Share to LinkedIn Share to Doximity
Contents
  1. CMS updates prior authorization transparency guidance in response to AMA recommendations
  2. While lawmakers are back in district this August, take action on key issues that need your voice
  3. AMA responds to NIH request for information on strengthening rigor and impact of biomedical research
  4. AMA submits comments urging CMS to strengthen Medicare drug price negotiation
  5. More articles in this issue

CMS updates prior authorization transparency guidance in response to AMA recommendations

The Centers for Medicare & Medicaid Services (CMS) recently updated its guidance on federal prior authorization (PA) transparency requirements, incorporating several recommendations the AMA made following its review of how 15 Medicare Advantage contracts implemented the reporting provisions of the 2024 Interoperability and Prior Authorization final rule (CMS-0057-F).

General email newsletter lean icon
Haven't subscribed?
Stay current on the latest issues impacting physicians, patients and healthcare with the AMA’s Advocacy Update newsletter.
Sign Up/Create Account

The review revealed a consistent pattern: Many payers appeared to comply with the rule while presenting disclosures in places and formats that made them difficult or impossible to find or use. Payers posted hundreds of pages of billing codes without plain-language descriptions, buried required disclosures behind physician or member portals and deep within plan websites, reported mathematically impossible statistics and turnaround times without units, and omitted entire categories of care from public reporting. 

The AMA documented these concerns and recommended corrective action in a May 2026 letter to CMS and reiterated several of those recommendations in its June 2026 comments (PDF) on CMS-0062-P, which would extend PA transparency reporting requirements to prescription drugs.

The updated guidance addresses several of these problems by:

  • Defining what it means for prior authorization information to be publicly accessible. CMS makes clear that disclosures are not publicly accessible if they are available only through password-protected portals or cannot be reached through ordinary navigation from a payer’s public-facing website.
  • Clarifying that prior authorization disclosures must be understandable. CMS explicitly says lists of procedure codes without plain-language descriptions do not satisfy the requirement and recommends a single, comprehensive list organized by uniform service categories, with CPT codes, plain-language descriptions, and a machine-readable format.
  • Standardizing how payers calculate reported outcomes. CMS now specifies the expected numerator and denominator for each metric, preventing payers from omitting entire categories of care from prior authorization reporting.
  • Improving the accuracy and reliability of reported data. CMS clarifies that every turnaround-time metric must include a unit of time and requires median turnaround times of less than one day to be reported in hours rather than rounded to “0 days.” The agency also recommends that payers explain any data quality issue in their reporting by identifying the affected metric(s) and describing the limitation or quality concern.

As CMS moves to expand PA reporting requirements to prescription drugs, the AMA will continue working with the agency to ensure its transparency policies deliver on their promise of helping patients make informed decisions about their care, physicians navigate PA requirements, and regulators hold payers accountable for delays and denials—ultimately improving timely access to care for patients and reducing unnecessary burdens on physicians.

While lawmakers are back in district this August, take action on key issues that need your voice

With the August congressional district work period already underway, now is the time to maximize opportunities to elevate the AMA's top federal priorities impacting patients and physicians. Watch a recently recorded webinar that provides an update on the key legislative issues that need your voice and how AMA physician advocates can work to raise awareness of these priorities with their lawmakers during the remainder of the recess. Then use the 2026 recess engagement toolkit (PDF) to take action on these issues with your members of Congress while they are back in their districts. 

Your grassroots efforts now can help build momentum for more extensive in-district advocacy when Congress returns this fall—contact Congress now.

AMA responds to NIH request for information on strengthening rigor and impact of biomedical research

On Aug. 18, the AMA submitted comments (PDF) to the National Institutes of Health (NIH) in response to its Request for Information on Measuring and Rewarding Scientific Impact, recommending steps to strengthen the rigor, clinical relevance, and impact of federally supported biomedical research.

Specifically, the AMA urged NIH to:

  • Fund the research questions patients and physicians most need answered. NIH should solicit physician input to identify the most pressing evidence gaps in clinical practice and direct research funding to address them.
  • Increase investment in comparative effectiveness research (CER) and cost-effectiveness analysis (CEA). Increased investment in CER and CEA, coupled with stronger requirements for appropriate trial comparators, would give physicians better evidence to assess the benefits, harms, and relative value of available treatments and promote high-value care.
  • Strengthen methodological standards for NIH-supported research. NIH should require studies to use clinically relevant endpoints, adequate follow-up, representative populations, and care settings, and prespecified methods so physicians can rely on their findings to inform patient care.
  • Strengthen and enforce data-sharing requirements. NIH should make reporting and data sharing a condition of funding so thatresearch findings can be independently tested, reused, and built upon—accelerating discovery and improving the evidence available to physicians and patients.
  • Protect scientific independence and federal research investments. NIH should safeguard the integrity and continuity of federally supported research by prohibiting political interference in peer review, establishing transparent standards for decisions that depart from scientific review recommendations, protecting ongoing research from arbitrary termination, and maintaining timely annual disbursement of appropriated research funds.

The AMA will continue to advocate for federal research policies that produce rigorous, reliable evidence, accelerate scientific discovery, and improve patient care in the real world.

AMA submits comments urging CMS to strengthen Medicare drug price negotiation

On Aug. 14, the AMA submitted comments (PDF) to CMS on its proposed rule to codify policies governing the Medicare Drug Price Negotiation Program. 

In the comments, the AMA reaffirmed its longstanding support for Medicare drug price negotiation and urged CMS to strengthen the proposed regulations to promote a transparent, clinically grounded process that maximizes savings for patients and the Medicare program alike.

Specifically, the AMA urged CMS to:

  • Increase transparency throughout the drug negotiation process. CMS should provide enough information for physicians, patients, and the public to understand why drugs were selected, how maximum fair prices (MFPs) were determined, and how statutory factors affected the final price.
  • Strengthen the use of clinical evidence and physician and patient input. When direct comparative evidence is limited, CMS should identify evidence gaps and account for uncertainty. CMS should also incorporate physician and patient input on clinically important differences between therapies that studies may not capture.
  • Account for manufacturer investment, financial returns and practices that delay competition. CMS should consider taxpayer support for drug development, whether manufacturers have already recouped their investments and the use of strategies such as patent thickets and product hopping to prolong higher prices.
  • Protect access to physician-administered drugs. CMS should ensure physician practices can acquire negotiated Part B drugs at the MFP rather than requiring them to finance the difference and await reimbursement, which could jeopardize access to treatment, particularly in smaller and independent practices.

As CMS finalizes implementation of the Medicare Drug Price Negotiation Program, the AMA will continue to advocate for policies that strengthen the integrity and effectiveness of the negotiation process and protect patient access to critical drugs.

More articles in this issue

  • Top stories of Advocacy Update: August 2026
Your Powerful Ally
Through AMA advocacy and policymaking, we are addressing the issues important to you—together—and shaping what’s next for physicians.
Join Us
 
  • AMA Advocacy Update
  • Federal Advocacy
  • Prior Authorization
  • Catalog of Topics

FEATURED STORIES

Man power walking or jogging, with dumbbells

New changes expand diabetes-prevention for more Medicare patients

Nov 13, 2026 | 3 Min Read
Three healthcare workers in discussion

AMA Joy in Medicine points the way to better care

Nov 17, 2026 | 5 Min Read
Doctors hold up magnifying glasses over a giant pancreas

Beyond watch and wait: Taking aim at pancreatic cysts

Nov 16, 2026 | 7 Min Read
Philip Kuriakose, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about microplastics

Nov 10, 2026 | 8 Min Read
Discover More:
  • Jan. 9, 2026: National Advocacy Update
  • Jan. 16, 2026: National Advocacy Update
  • Feb. 27, 2026: National Advocacy Update

Sign up for the AMA newsletter and stay current.

American Medical Association

The AMA promotes the art and science of medicine and the betterment of public health.

Our Work

  • Prior authorization
  • Medicare payment reform
  • Physician-led care
  • Organizational well-being
  • Digital health & AI
  • State advocacy
  • Explore all topics

Career Resources

  • Career Advancement Collective
  • CME from AMA Ed Hub™
  • FREIDA™
  • AMA UME Curricular Enrichment Program
  • AMA GME Competency Education Program (GCEP)
  • AMA Physician Education Program
  • AMA Physician Profiles

About

  • Membership
  • Press Center
  • Policy
  • Code of Medical Ethics
  • Newsletters
  • Video
  • Podcasts
  • Events
  • Careers
  • Contact Us

Affiliates & Subsidiaries

  • AMPAC
  • AMA Foundation
  • AMA Alliance
  • AMA Insurance
  • Health2047

PRODUCTS

  • FREIDA™
  • CME from AMA Ed Hub™
  • JAMA Network™
  • GCEP
  • AMA Journal of Ethics
  • CPT®
  • AMA Store
  • AMA Physician Profiles
  • AMA Insurance
  • Code of Conduct
  • Terms of Use
  • Privacy Policy
  • Website Accessibility
  • Share Your Screen
Copyright 1995 - 2026 American Medical Association. All rights reserved.

Connect: